AU2009202940A1 - Solid film, rapidly dissolvable in liquids - Google Patents
Solid film, rapidly dissolvable in liquids Download PDFInfo
- Publication number
- AU2009202940A1 AU2009202940A1 AU2009202940A AU2009202940A AU2009202940A1 AU 2009202940 A1 AU2009202940 A1 AU 2009202940A1 AU 2009202940 A AU2009202940 A AU 2009202940A AU 2009202940 A AU2009202940 A AU 2009202940A AU 2009202940 A1 AU2009202940 A1 AU 2009202940A1
- Authority
- AU
- Australia
- Prior art keywords
- film
- solid film
- solid
- polysorbate
- products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000007787 solid Substances 0.000 title claims description 38
- 239000007788 liquid Substances 0.000 title claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 239000003995 emulsifying agent Substances 0.000 claims description 22
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 20
- 235000011187 glycerol Nutrition 0.000 claims description 20
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 19
- 235000010413 sodium alginate Nutrition 0.000 claims description 19
- 239000000661 sodium alginate Substances 0.000 claims description 19
- 229940005550 sodium alginate Drugs 0.000 claims description 19
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 18
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 18
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 18
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 18
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 15
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 15
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 15
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 15
- 229940068968 polysorbate 80 Drugs 0.000 claims description 15
- 229920000053 polysorbate 80 Polymers 0.000 claims description 15
- 239000000600 sorbitol Substances 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 11
- 239000000080 wetting agent Substances 0.000 claims description 11
- 230000001804 emulsifying effect Effects 0.000 claims description 8
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 7
- 229920002674 hyaluronan Polymers 0.000 claims description 7
- 229960003160 hyaluronic acid Drugs 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 235000010980 cellulose Nutrition 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 6
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 6
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 6
- 229940113124 polysorbate 60 Drugs 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 235000009973 maize Nutrition 0.000 claims description 3
- 229920005862 polyol Polymers 0.000 claims description 3
- 150000003077 polyols Chemical class 0.000 claims description 3
- -1 polyoxyethylene Polymers 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 235000012015 potatoes Nutrition 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 240000008886 Ceratonia siliqua Species 0.000 claims description 2
- 235000013912 Ceratonia siliqua Nutrition 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 239000004373 Pullulan Substances 0.000 claims description 2
- 229920001218 Pullulan Polymers 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 239000001087 glyceryl triacetate Substances 0.000 claims description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229920001206 natural gum Polymers 0.000 claims description 2
- 230000000144 pharmacologic effect Effects 0.000 claims description 2
- 235000019423 pullulan Nutrition 0.000 claims description 2
- 229960002622 triacetin Drugs 0.000 claims description 2
- 238000009736 wetting Methods 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 150000002337 glycosamines Chemical class 0.000 claims 1
- 238000013019 agitation Methods 0.000 description 32
- 239000000047 product Substances 0.000 description 31
- 239000000203 mixture Substances 0.000 description 21
- 229920000728 polyester Polymers 0.000 description 10
- 239000000499 gel Substances 0.000 description 9
- 239000004014 plasticizer Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 239000008247 solid mixture Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 210000002200 mouth mucosa Anatomy 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 5
- 229960003987 melatonin Drugs 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 230000002572 peristaltic effect Effects 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 239000010703 silicon Substances 0.000 description 5
- 238000010583 slow cooling Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 238000011017 operating method Methods 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000000935 solvent evaporation Methods 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 3
- 235000019759 Maize starch Nutrition 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 244000124209 Crocus sativus Species 0.000 description 2
- 235000015655 Crocus sativus Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 229960002983 loperamide hydrochloride Drugs 0.000 description 2
- PGYPOBZJRVSMDS-UHFFFAOYSA-N loperamide hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 PGYPOBZJRVSMDS-UHFFFAOYSA-N 0.000 description 2
- 239000008368 mint flavor Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000013974 saffron Nutrition 0.000 description 2
- 239000004248 saffron Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 206010003497 Asphyxia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000002937 anti-propulsive effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940110716 cicatrizants Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 229960001571 loperamide Drugs 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000008667 sleep stage Effects 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/79—Fixation, conservation, or encapsulation of flavouring agents in the form of films
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Detergent Compositions (AREA)
- Jellies, Jams, And Syrups (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001450A ITMI20081450A1 (it) | 2008-08-04 | 2008-08-04 | Pellicola solida a rapida dissoluzione nei liquidi |
| ITMI2008A001450 | 2008-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2009202940A1 true AU2009202940A1 (en) | 2010-02-18 |
Family
ID=40460028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009202940A Abandoned AU2009202940A1 (en) | 2008-08-04 | 2009-07-21 | Solid film, rapidly dissolvable in liquids |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9272067B2 (enExample) |
| EP (1) | EP2151252B1 (enExample) |
| JP (1) | JP2010037339A (enExample) |
| KR (1) | KR20100015294A (enExample) |
| CN (1) | CN101708176A (enExample) |
| AU (1) | AU2009202940A1 (enExample) |
| CA (1) | CA2674116A1 (enExample) |
| IT (1) | ITMI20081450A1 (enExample) |
| RU (1) | RU2009129707A (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1019216A3 (nl) * | 2010-03-11 | 2012-04-03 | Sylphar | Kleefpleister voor de toediening van therapeutische agentia. |
| EP2544669A1 (en) * | 2010-03-11 | 2013-01-16 | Sylphar | Adhesive patch for therapeutic agent delivery |
| WO2012116491A1 (zh) * | 2011-03-02 | 2012-09-07 | 深圳市如烟生物科技有限公司 | 凝胶态水溶性烟用香精制备方法 |
| WO2013110340A1 (en) * | 2012-01-27 | 2013-08-01 | Beta Pharma S.A. | Edible slow dissolving film for treating oral ulcerations |
| ITMI20121248A1 (it) * | 2012-07-18 | 2014-01-19 | Mediolanum Farmaceutici Srl | Film idrosolubile ad attivita' cicatrizzante. |
| CA2878680C (en) | 2012-07-23 | 2019-09-17 | Crayola, Llc | Dissolvable films and methods of using the same |
| US10704169B2 (en) | 2014-08-29 | 2020-07-07 | Southern Mills, Inc. | Flame resistant fabrics having cellulosic filament yarns |
| CN106176286B (zh) * | 2016-08-30 | 2019-05-28 | 华熙生物科技股份有限公司 | 透明质酸皮肤护理膜及制备方法和应用 |
| WO2018173008A1 (en) * | 2017-03-24 | 2018-09-27 | Sumesa S.A. | Food product with fat free binder |
| EP3704946A1 (en) * | 2019-03-07 | 2020-09-09 | Viscofan, S.A. | Edible tubular food casings and method for their production |
| US20220144517A1 (en) * | 2019-06-25 | 2022-05-12 | Decomer Technology Inc. | Hydro-liquid soluble films, products and uses thereof |
| CN111357991A (zh) * | 2020-03-18 | 2020-07-03 | 华熙生物科技股份有限公司 | 一种可食用水溶纸及其制备方法 |
| EP4144342A1 (fr) * | 2021-09-02 | 2023-03-08 | Polybridge | Ensemble comportant un produit d hygiène de douche ou de bain enveloppé dans un film hydrosoluble fonctionnel |
| FR3126306B1 (fr) * | 2021-09-02 | 2025-01-17 | Polybridge | Ensemble comportant un produit d’hygiène de douche ou de bain enveloppé dans un film hydrosoluble fonctionnel |
| WO2024212004A1 (en) * | 2023-04-13 | 2024-10-17 | Reg Macquarrie | Film-based skin care products for topical application |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3582357A (en) * | 1969-03-24 | 1971-06-01 | Pillsbury Co | Edible mix composition for producing an aerated product |
| JPH10251132A (ja) * | 1997-03-13 | 1998-09-22 | Mansouri Zara | 物質を皮膚内へ送達する方法およびそれに使用される組成物 |
| US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
| DE10129539A1 (de) * | 2001-06-22 | 2003-01-09 | Kalle Gmbh & Co Kg | Cellulosehaltige, eßbare Folie |
| US6656493B2 (en) * | 2001-07-30 | 2003-12-02 | Wm. Wrigley Jr. Company | Edible film formulations containing maltodextrin |
| WO2003043659A1 (en) * | 2001-11-16 | 2003-05-30 | Givaudan Sa | Edible film |
| KR20040062680A (ko) * | 2001-12-13 | 2004-07-07 | 테크콤 인터내셔날 인크. | 고단백질, 저탄수화물 도우 및 빵 생성물, 및 그의 제조방법 |
| US20050003048A1 (en) * | 2002-02-11 | 2005-01-06 | Edizone, Lc | Electrolyte-containing orally soluble films |
| US8999372B2 (en) * | 2002-11-14 | 2015-04-07 | Cure Pharmaceutical Corporation | Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use |
| US20040115137A1 (en) * | 2002-12-17 | 2004-06-17 | Verrall Andrew P. | Water-soluble film for oral administration |
| MXPA05011026A (es) * | 2003-04-14 | 2005-12-12 | Fmc Corp | Pelicula de gel termo-reversible homogenea que contiene carragenano kappa-2 y capsulas blandas hechas a partir de la misma. |
| ITMI20031291A1 (it) * | 2003-06-25 | 2004-12-26 | Ricerfarma Srl | Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale. |
| US20050075432A1 (en) * | 2003-10-07 | 2005-04-07 | Verrall Andrew P. | Acidulent film and method of making same |
| HRP20090407T1 (hr) * | 2003-10-10 | 2009-09-30 | Cosmedical Aps | Inhibicija rasta dlaka |
| JP4570866B2 (ja) * | 2003-12-16 | 2010-10-27 | 林兼産業株式会社 | 常温保管及び常温流通可能な養殖魚用固形飼料 |
| JP4493537B2 (ja) * | 2004-05-27 | 2010-06-30 | 江崎グリコ株式会社 | 液体またはペースト含有ルウ製品及びその製造方法 |
| TR201907874T4 (tr) * | 2004-09-23 | 2019-06-21 | Arc Medical Devices Inc | Düşük sülfat fukanlar kullanarak fibröz yapışmaları ya da inflamatuar hastalıkları inhibe etmeye yönelik farmasötik kompozisyonlar ve yöntemler. |
| JP2006280204A (ja) * | 2005-03-31 | 2006-10-19 | Fuji Oil Co Ltd | パンの製造法 |
| ITMI20051228A1 (it) * | 2005-06-29 | 2006-12-30 | Biofarmitalia Spa | Film edibile antifame rapidamente solubile in acqua e contenente fibre che si rigonfiano in presenza di acqua |
| JP4913386B2 (ja) * | 2005-10-25 | 2012-04-11 | 株式会社明治 | 食品品質の自動検査装置および検査方法 |
| ITMI20061933A1 (it) * | 2006-10-09 | 2008-04-10 | Biofarmitalia Spa | Composizioni solide cosmetiche e terapeutiche applicabili sulla pelle umana e gelificabili a contatto con acqua |
| US20080220029A1 (en) * | 2007-03-05 | 2008-09-11 | Charlene Ng | Fast-dissolving/disintegrating film preparation having high proportion of active |
-
2008
- 2008-08-04 IT IT001450A patent/ITMI20081450A1/it unknown
-
2009
- 2009-07-21 AU AU2009202940A patent/AU2009202940A1/en not_active Abandoned
- 2009-07-22 CA CA002674116A patent/CA2674116A1/en not_active Abandoned
- 2009-07-23 US US12/508,044 patent/US9272067B2/en active Active
- 2009-07-27 EP EP09166503A patent/EP2151252B1/en active Active
- 2009-07-30 JP JP2009177244A patent/JP2010037339A/ja active Pending
- 2009-08-03 RU RU2009129707/15A patent/RU2009129707A/ru not_active Application Discontinuation
- 2009-08-03 KR KR1020090071447A patent/KR20100015294A/ko not_active Withdrawn
- 2009-08-04 CN CN200910221474A patent/CN101708176A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20081450A1 (it) | 2010-02-05 |
| US20100029790A1 (en) | 2010-02-04 |
| RU2009129707A (ru) | 2011-02-10 |
| EP2151252A2 (en) | 2010-02-10 |
| JP2010037339A (ja) | 2010-02-18 |
| KR20100015294A (ko) | 2010-02-12 |
| CA2674116A1 (en) | 2010-02-04 |
| US9272067B2 (en) | 2016-03-01 |
| EP2151252B1 (en) | 2013-03-13 |
| CN101708176A (zh) | 2010-05-19 |
| EP2151252A3 (en) | 2012-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9272067B2 (en) | Solid film, rapidly dissolvable in liquids | |
| US8840935B2 (en) | Orally administrable films and preparation thereof | |
| Karki et al. | Thin films as an emerging platform for drug delivery | |
| DE69930964T2 (de) | Zusammensetzungen und verfahren für mukosale abgabe | |
| RU2242968C2 (ru) | Быстродиспергирующаяся лекарственная форма, не содержащая желатин | |
| CA2678876C (en) | Orally administrable films | |
| US20070042023A1 (en) | Dissolvable film | |
| US20050186257A1 (en) | Dissolvable film and method of manufacture | |
| AU753292B2 (en) | Bioadhesive antibacterial wound healing composition | |
| US20080124381A1 (en) | Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents | |
| ES2294180T3 (es) | Composiciones de beta-glucano de cereales, metodos de preparacion y usos de las mismas. | |
| WO2009073190A1 (en) | Fast dissolving films and coatings for controlled release of flavors, active pharmaceutical ingredients, food substances, and nicotine | |
| JP6519930B2 (ja) | 水溶性ヒアルロン酸ゲル及びその製造方法 | |
| CN110302144B (zh) | 一种缓释型双层口腔溃疡膜及其制备方法 | |
| CN101278948A (zh) | 一种生物型药膜及其制备方法 | |
| US20110269844A1 (en) | Thin film with propofol active ingredient | |
| JP2879695B2 (ja) | 口腔内粘膜付着性フィルム製剤 | |
| CN116459258A (zh) | 依克多因在制备预防或抑制由乙醛引起的细胞损伤产品中的应用 | |
| CN109771395B (zh) | 一种含有槲皮素的口腔黏膜剂及其制备方法 | |
| JP2013216682A (ja) | フィルム及びフィルム形成性組成物 | |
| Wargantiwar et al. | Biocompatible Natural Polymers and Cutting-Edge Fabrication Techniques in the Development of Next-Generation Oral Thin Films for Enhanced Drug Delivery Systems | |
| EP2688551A1 (en) | A composition and method | |
| WO2009055923A1 (en) | Ingestible film composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |